MOTS-c: Research Evidence & Trials
This guide collects everything we’ve researched on MOTS-c in the area of research evidence & trials. Each question below contrasts what AI assistants report with what the peer-reviewed literature in our research corpus actually shows.
Questions in this guide
- What is the quality and consistency of human clinical evidence supporting MOTS-c’s metabolic benefits, and how many randomized controlled trials exist?
- How do in vitro studies on MOTS-c compare with in vivo findings in terms of reproducibility and biological relevance?
- What is the current status of MOTS-c in clinical development—phase I, II, or beyond—and what are the primary endpoints?
- What are the limitations of existing studies on MOTS-c, particularly regarding sample size and duration?
Continue your journey
How does MOTS-c interact with mitochondrial pathways to modulate cellular energy homeostasis and reduce oxidative stress?What are the limitations of existing studies on MOTS-c, particularly regarding sample size and duration?How does MOTS-c compare to other mitochondrial peptides like SHLP2 or humanin in longevity and metabolic regulation?What are the documented metabolic benefits of MOTS-c supplementation in humans with insulin resistance or prediabetes?MOTS-c: Practical & Buying GuidanceHave any adverse events been reported in human trials involving MOTS-c supplementation?